Filing Details
- Accession Number:
- 0001104659-13-001077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-07 18:46:15
- Reporting Period:
- 2013-01-03
- Filing Date:
- 2013-01-07
- Accepted Time:
- 2013-01-07 18:46:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537668 | G Christopher White | C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-03 | 10,000 | $0.00 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-04 | 4,000 | $16.03 | 6,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2013-01-03 | 10,000 | $0.00 | 10,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | No | 4 | M | Direct |
Footnotes
- The shares were acquired by the reporting person as a result of the partial vesting of the restricted stock unit grant described below.
- Not applicable.
- The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold on this date. The actual sales prices per share range from $15.71-$16.37. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc. (the "Issuer"), or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- Grant of restricted stock unit pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in three installments. The first installment of 10,000 restricted stock units vested on January 3, 2013. The remaining two installments of 5,000 restricted stock units each will vest on January 3, 2014 and January 3, 2015, respectively.
Billionaire Hedge Funds
